BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14508276)

  • 1. Pelvic anatomic localization using ureteral activity on FDG positron emission tomography.
    Lin EC; Siegal J
    Clin Nucl Med; 2003 Oct; 28(10):836-7. PubMed ID: 14508276
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
    Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
    Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases.
    Nguyen JD; Carrasquillo JA; Little RF; Ryan QC; Wilson W; Chen CC
    Clin Nucl Med; 2003 Dec; 28(12):979-80. PubMed ID: 14663321
    [No Abstract]   [Full Text] [Related]  

  • 4. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification.
    Tsukamoto N; Kojima M; Hasegawa M; Oriuchi N; Matsushima T; Yokohama A; Saitoh T; Handa H; Endo K; Murakami H
    Cancer; 2007 Aug; 110(3):652-9. PubMed ID: 17582800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG positron emission tomography in lymphoma.
    Tecnologica MAP Suppl; 2000 Jan; ():9-10. PubMed ID: 10848116
    [No Abstract]   [Full Text] [Related]  

  • 6. Skeletal muscle uptake detected on FDG PET 48 hours after exertion.
    Gradinscak DJ; Fulham MJ; Mohamed A; Constable CJ
    Clin Nucl Med; 2003 Oct; 28(10):840-1. PubMed ID: 14508278
    [No Abstract]   [Full Text] [Related]  

  • 7. Positron emission tomographic-computed tomographic imaging of a uterine sarcoma.
    Cher S; Lay Ergun E
    Clin Nucl Med; 2003 May; 28(5):443-4. PubMed ID: 12702956
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY; Kao A; Yen RF
    Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar pelvic abnormalities on FDG positron emission tomography of different origins.
    Zhuang H; Yamamoto AJ; Sinha P; Pourdehnad M; Liu Y; Alavi A
    Clin Nucl Med; 2001 Jun; 26(6):515-7. PubMed ID: 11353298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography/computed tomography fusion imaging in brown adipose tissue.
    Minotti AJ; Shah L; Keller K
    Clin Nucl Med; 2004 Jan; 29(1):5-11. PubMed ID: 14688591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fortuitous detection of papillary carcinoma of the thyroid with F-18 FDG positron emission tomography in a patient with non-Hodgkin lymphoma.
    Kim CE; Joyce JM; Patel N; Lichter J
    Clin Nucl Med; 2003 Sep; 28(9):782-3. PubMed ID: 12973010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Hodgkin's lymphoma of the bone can mimic osteomyelitis on FDG PET.
    Chamroonrat W; Houseni M; Bing Z; Yang H; Alavi A; Zhuang H
    Clin Nucl Med; 2007 Mar; 32(3):252-4. PubMed ID: 17314615
    [No Abstract]   [Full Text] [Related]  

  • 13. FDG PET imaging in patients with lymphoma: a clinical perspective.
    Segall GM
    J Nucl Med; 2001 Apr; 42(4):609-10. PubMed ID: 11337550
    [No Abstract]   [Full Text] [Related]  

  • 14. Technical improvements in fluorine-18-FDG PET imaging of the abdomen and pelvis.
    Leisure GP; Vesselle HJ; Faulhaber PF; O'Donnell JK; Adler LP; Miraldi F
    J Nucl Med Technol; 1997 Jun; 25(2):115-9. PubMed ID: 9239615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-Fluorodeoxyglucose PET in a patient with primary small bowel lymphoma: the only sensitive method of imaging.
    Ullerich H; Franzius CH; Domagk D; Seidel M; Sciuk J; Schober ; Domschke W
    Am J Gastroenterol; 2001 Aug; 96(8):2497-9. PubMed ID: 11513199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET utility in paraneoplastic sweet syndrome.
    Krug B; Sonet A; Pirson AS; Mahy N; Bosly A; Borght TV
    Clin Nucl Med; 2004 Feb; 29(2):91-2. PubMed ID: 14734904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid nodule mimicking cervical adenopathy on FDG positron emission tomographic imaging.
    Lin EC
    Clin Nucl Med; 2002 Sep; 27(9):656-7. PubMed ID: 12192285
    [No Abstract]   [Full Text] [Related]  

  • 18. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.
    Antoch G; Freudenberg LS; Beyer T; Bockisch A; Debatin JF
    J Nucl Med; 2004 Jan; 45 Suppl 1():56S-65S. PubMed ID: 14736836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
    Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
    Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral testicular relapse of abdominal non-Hodgkin lymphoma detected by FDG-PET.
    Basu S; Nair N
    Pediatr Radiol; 2006 Mar; 36(3):274-5. PubMed ID: 16328321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.